Concepedia

Shengjiang Chen

SC

Statistics

Publications

2

Citations

29

H-Index

2

Active since

2017

Affiliations

First Affiliated Hospital of Henan University of Science and Technology(Current)

Shengjiang Chen is an author at First Affiliated Hospital of Henan University of Science and Technology specializing in tumor immunity, immunology, and cell biology.

ORCID

Top concepts

Publications per year

2017–2022

2

Publications

2

miR-139 acts as a tumor suppressor in T-cell acute lymphoblastic leukemia by targeting CX chemokine receptor 4.

Ling Qin, Hui-Yang Deng, Shengjiang Chen et al. · PubMed · 2017 · 18 citations

, , +13

GATA binding protein 1 recruits histone deacetylase 2 to the promoter region of nuclear receptor binding protein 2 to affect the tumor microenvironment and malignancy of thyroid carcinoma

Mengyuan Li, Hongwei� Jiang, Shengjiang Chen et al. · Bioengineered · 2022 · 11 citations · Full text

Rows per page

1–2 of 2